Actualité

Sophie PRIVAULT, ingénieure d’études, CERMES3-CNRS, Jeremy K. WARD, chargé de recherche CERMES3-INSERM

Brosset E, Anderson E, Garrison A, Holford D, Fisher H, Peretti-Watel P, Lewandowsky S, and Verger P. Healthcare Professionals’ Emotions of Distance and Connection When Dealing With Patients’ Vaccine Hesitancy: Interaction Styles, Values, and Implications. Qualitative Health Research. 2025;0(0). doi:10.1177/10497323251320921 Abstract Healthcare professionals (HCPs) play a primary role in the delivery of population-based vaccination programs….

Gauna, F., Raude, J., Khouri, C., Cracowski, J. L., & Ward, J. K. (2025). Exploring the relationship between experience of vaccine adverse events and vaccine hesitancy: A scoping review. Human Vaccines & Immunotherapeutics, 21(1). https://doi.org/10.1080/21645515.2025.2471225 Abstract Fear of side effects is the main motive for vaccine refusal. However, before the COVID-19 pandemic, little attention had been paid…

Retrouvez l’ensemble des vidéos et des présentations des interventions lors de la 1ère journée d’études du réseau SHS-vaccination « Les professionnels de santé, acteurs et sujets de la vaccination ».Cette journée d’études a eu lieu le 24 janvier 2025, à l’Université Paris Cité, campus Saint-Germain des Prés.

Date : du 11 au 12 juin 2025 Lieu : Universidade de Évora, Évora, Portugal Conférence : European Sociological Association, Research Network 16 – Sociology of Health & Medicine Mid-term Conference Parmi les sessions : Session 1: Epidemics and Pandemics in the Digital Age: ‘Contested knowledge’, Health and Vaccine Acceptance Session convener: Eve Dubé Abstract…

É Schultz, JK Ward, L Atlani-Duault, Science and public policy 51 (2), 236-246 Abstract During the Covid-19 pandemic, many governments have resorted to scientific advisory bodies to aid in public health decision-making. What then has been the public’s perception of those new structures of scientific advice? In this article, we draw on a survey conducted…

P Peretti-Watel, P Verger, JK Ward, Nature Medicine 30 (4), 923-924 Abstract The COVID-19 pandemic acceler-ated the development of mRNA vaccines and provided proof of concept for this new approach to protect humans against infectious diseases, as well as other diseases such as cancer. However, the use of mRNA technology depends on the public’s attitude…